EUVIMEDEUVIMED entdecken
Crossref

Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K / mTOR / HIF1α pathway and increasing oxidative stress in colon cancer cells

Wesam F Farrash, Akhmed Aslam, Riyad Almaimani, Faisal Minshawi, Hussain Almasmoum, Aiman Alsaegh, Mohammad S Iqbal, Aisha Tabassum, Mohamed E Elzubier, Mahmoud Z El-Readi, Amani A Mahbub, Shakir Idris und 1 weitere

BioFactors · 2023

DOI: 10.1002/biof.1947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioFactors, 2023. Verfasst von Wesam F Farrash und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia. Hauptthemen laut MEDLINE: Colonic Neoplasms, Fluorouracil, Metformin. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: The Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the chemotherapeutic effects of 5‐fluorouracil (5‐FU), metformin (Met), and/or thymoquinone (TQ) single/dual/triple therapies in the HT29, SW480 and SW620 colon cancer (CRC) cell lines. Cell cycle/apoptosis were measured by flow cytometry. The gene and protein expression of apoptosis (PCNA/survivin/BAX/Cytochrome‐C/Caspase‐3) and cell cycle (CCND1/CCND3/p21/p27) molecules, the PI3K/mTOR/HIF1α oncogenic pathway, and glycolysis regulatory enzymes were measured by quantitative‐PCR and Western blot. Markers of oxidative stress were also measured by colorimetric assays. Although all treatments induced anti‐cancer effects related to cell cycle arrest and apoptosis, the triple therapy showed the highest pro‐apoptotic actions that coincided with the lowest expression of CCND1/CCND3/PCNA/survivin and the maximal increases in p21/p27/BAX/Cytochrome‐C/Caspase‐3 in all cell lines. The triple therapy also revealed the best suppression of the PI3K/mTOR/HIF1α pathway by increasing its endogenous inhibitors (PTEN/AMPKα) in all cell lines. Moreover, the lowest expression of lactate dehydrogenase and pyruvate dehydrogenase kinase‐1 with the highest expression of pyruvate dehydrogenase were seen with the triple therapy, which also showed the highest increases in oxidative stress markers (ROS/RNS/MDA/protein carbonyl groups) alongside the lowest antioxidant levels (GSH/CAT) in all cell lines. In conclusion, this is the first study to reveal enhanced anti‐cancer effects for metformin/thymoquinone in CRC that were superior to all monotherapies and the other dual therapies. However, the triple therapy approach showed the best tumoricidal actions related to cell cycle arrest and apoptosis in all cell lines, possibly by enhancing oxidative glycolysis and augmenting oxidative stress through stronger modulation of the PI3K/mTOR/HIF1α oncogenic network.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsFluorouracilMetforminHumansApoptosisbcl-2-Associated X ProteinCaspase 3Cell Line, TumorCell ProliferationCytochromesOxidative StressPhosphatidylinositol 3-KinasesProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-aktSurvivinTOR Serine-Threonine KinasesHypoxia-Inducible Factor 1, alpha SubunitBenzoquinones

Stichwörter der Autor:innen

apoptosiscell cyclechemoresistanceglycolysisoxidative stress

Substanzen

bcl-2-Associated X ProteinCaspase 3CytochromesFluorouracilMetforminPhosphatidylinositol 3-KinasesProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-aktSurvivinTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Biochemistry Department, Faculty of Pharmacy, Al-Azhar University, Assuit, Egypt.

ORCID-Profile: Bassem Refaat

Förderung

  • The Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia

Zitieren

APA

Farrash, W. F., Aslam, A., Almaimani, R., Minshawi, F., Almasmoum, H., Alsaegh, A., Iqbal, M. S., Tabassum, A., Elzubier, M. E., El-Readi, M. Z., Mahbub, A. A., Idris, S., & Refaat, B. (2023). Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K / mTOR / HIF1α pathway and increasing oxidative stress in colon cancer cells. BioFactors. https://doi.org/10.1002/biof.1947

Vancouver

Farrash WF, Aslam A, Almaimani R, Minshawi F, Almasmoum H, Alsaegh A, et al. Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K / mTOR / HIF1α pathway and increasing oxidative stress in colon cancer cells. BioFactors. 2023. doi:10.1002/biof.1947

BibTeX
@article{Farrash2023,
  author = {Farrash, Wesam F and Aslam, Akhmed and Almaimani, Riyad and Minshawi, Faisal and Almasmoum, Hussain and Alsaegh, Aiman and Iqbal, Mohammad S and Tabassum, Aisha and Elzubier, Mohamed E and El-Readi, Mahmoud Z and Mahbub, Amani A and Idris, Shakir and Refaat, Bassem},
  title = {Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K / mTOR / HIF1α pathway and increasing oxidative stress in colon cancer cells},
  journal = {BioFactors},
  year = {2023},
  doi = {10.1002/biof.1947}
}
Kostenlos starten →